New prospects for mucosal immunization: anti-infectious and anti-inflammatory vaccines (original) (raw)

Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies

Andy Miller

Vaccine, 2002

View PDFchevron_right

Mucosal immunisation and adjuvants: a brief overview of recent advances and challenges

Cecil Czerkinsky

Vaccine, 2003

View PDFchevron_right

Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections

Sergio Arce

Journal of Dental Research, 2005

View PDFchevron_right

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants

Jerry McGhee

Vaccine, 2002

View PDFchevron_right

Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses

Cecil Czerkinsky

The Journal of Immunology, 2003

View PDFchevron_right

B Lymphocytes Promote Expansion of Regulatory T Cells in Oral Tolerance: Powerful Induction by Antigen Coupled to Cholera Toxin B Subunit

Cecil Czerkinsky

The Journal of Immunology, 2008

View PDFchevron_right

The combined CTA1-DD/ISCOM adjuvant vector promotes priming of mucosal and systemic immunity to incorporated antigens by specific targeting of B cells

Karin Lovgren

The Journal of …, 2006

View PDFchevron_right

Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA

Cecil Czerkinsky

Expert Review of Vaccines, 2003

View PDFchevron_right

Oral Tolerance Revisited: Prior Oral Tolerization Abrogates Cholera Toxin-Induced Mucosal IgA Responses

Kohtaro Fujihashi

The Journal of Immunology, 2001

View PDFchevron_right

Systemic tolerance and secretory immunity after oral immunization

Stephen Challacombe

The Journal of experimental medicine, 1980

View PDFchevron_right

Optimizing oral vaccines: induction of systemic and mucosal B-cell and antibody responses to tetanus toxoid by use of cholera toxin as an adjuvant

Jerry McGhee

Infection and immunity, 1993

View PDFchevron_right

Oral Mucosal Tolerance Versus Systemic Immune Response to Salmonella typhi Antigen

Ibrahim Shnawa

American Journal of Biomedical and Life Sciences

View PDFchevron_right

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

Reinaldo Acevedo Grogues

Expert Review of Vaccines, 2009

View PDFchevron_right

Pentabody-mediated antigen delivery induces antigen-specific mucosal immune response

Ted Fjallman

Molecular Immunology, 2009

View PDFchevron_right

Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues

Cecil Czerkinsky

Infection and Immunity, 1989

View PDFchevron_right

CTA1-DD-Immune Stimulating Complexes: a Novel, Rationally Designed Combined Mucosal Vaccine Adjuvant Effective with Nanogram Doses of Antigen

Peter Kaastrup

The Journal of Immunology, 2001

View PDFchevron_right

Novel vaccine development strategies for inducing mucosal immunity

Jerry McGhee

Expert Review of Vaccines, 2012

View PDFchevron_right

Immunology of the gut and oral tolerance

Umid Shrestha

Journal of Advances in Internal Medicine, 2015

View PDFchevron_right

Oral-Antigen Delivery by way of a Multiple Emulsion System Enhances Oral Tolerancea

Maurizio Tomasi

Annals of the New York Academy of Sciences, 1996

View PDFchevron_right

ORAL ROUTE AS METHOD FOR IMMUNIZING AGAINST MUCOSAL PATHOGENS

Arthur Jacknowitz

Annals of the New York Academy of Sciences, 1983

View PDFchevron_right

Mucosal immunity on the banks of the Duoro

P L Ogra

Human Vaccines, 2009

View PDFchevron_right

Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development

Kristina Eriksson

Infection and Immunity, 2003

View PDFchevron_right

Vaccines and mucosal immunisation

Allan Cripps

Vaccine, 2001

View PDFchevron_right

Development and use of mucosal vaccines: Potential and limitations

Silvia de Oliveira Hübner

2021

View PDFchevron_right

Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants

Giuseppe Giudice

Vaccine, 2001

View PDFchevron_right

Oral tolerance as antigen-specific immunotherapy

Licia Torres

Immunotherapy Advances, 2021

View PDFchevron_right

Intranasal Vaccination of Humans with Recombinant Cholera Toxin B Subunit Induces Systemic and Local Antibody Responses in the Upper Respiratory Tract and the Vagina

Eva Johansson

Infection and Immunity, 1997

View PDFchevron_right

Induction Proliferation During Oral Tolerance Antigen-Specific T Cell Activation and

Jiaren Sun

View PDFchevron_right

Mucosal immunity and vaccines

Cecil Czerkinsky

Nature Medicine, 2005

View PDFchevron_right

Vaccine Antigens Responses to Nasally Administered as an Adjuvant for Mucosal Immune

Alexandra Duverger

View PDFchevron_right

Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant

Helene Gras

European Journal of Immunology, 2002

View PDFchevron_right

Cholera toxin B subunit modulation of mucosal vaccines for infectious and autoimmune diseases

István Fodor, B. Denes

Current opinion in investigational drugs (London, England : 2000), 2010

View PDFchevron_right